An Overview of Pharmaceutical Excipients: Safe or Not Safe?
暂无分享,去创建一个
[1] Hamed Hamishehkar,et al. Evaluation of physicochemical properties and in vivo efficiency of atorvastatin calcium/ezetimibe solid dispersions. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[2] D. R. Karsa,et al. Excipients and Delivery Systems for Pharmaceutical Formulations , 2002 .
[3] Mohamed Ibrahim Noordin,et al. Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipients. , 2015, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[4] L. Block,et al. Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. , 1997, Pharmaceutical development and technology.
[5] George Zografi,et al. Water Vapor Sorption of Water-Soluble Substances: Studies of Crystalline Solids Below Their Critical Relative Humidities , 1987, Pharmaceutical Research.
[6] Raymond C Rowe,et al. Handbook of Pharmaceutical Excipients , 1994 .
[7] R. Strickley. Solubilizing Excipients in Oral and Injectable Formulations , 2004, Pharmaceutical Research.
[8] B. S. Rao,et al. Studies on enhancement of dissolution rate of etoposide , 2007 .
[9] K. Kawazoe,et al. Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[10] Mayyas Al-Remawi,et al. Chitin-silicon dioxide coprecipitate as a novel superdisintegrant. , 2008, Journal of pharmaceutical sciences.
[11] Phipps,et al. Application of isothermal microcalorimetry in solid state drug development. , 2000, Pharmaceutical science & technology today.
[12] Crowley. Excipients as stabilizers. , 1999, Pharmaceutical science & technology today.
[13] Andrew Teasdale,et al. ICH Q9 Quality Risk Management , 2017 .
[14] P. C. Buxton,et al. Degradation of glucose in the presence of electrolytes during heat sterilisation , 1994 .
[15] Chen Kuang,et al. Preparation and evaluation of taste masked oral suspension of arbidol hydrochloride , 2015 .
[16] M A Zoglio,et al. Pharmaceutical heterogeneous system. IV. A kinetic approach to the stability screening of solid dosage forms containing aspirin. , 1969, Journal of pharmaceutical sciences.
[17] Patrizia Restani,et al. The safety of pharmaceutical excipients. , 2003, Farmaco.
[18] S. Bharate,et al. Incompatibilities of Pharmaceutical Excipients with Active Pharmaceutical Ingredients: A Comprehensive Review , 2010 .
[19] N. Murti Vemuri,et al. Use of isothermal microcalorimetry in pharmaceutical preformulation studies , 2004 .
[20] D. Carrier,et al. A New Approach to Accelerated Drug-Excipient Compatibility Testing , 2003, Pharmaceutical development and technology.
[21] Odon Planinšek,et al. Determination of Solubility Parameters of Ibuprofen and Ibuprofen Lysinate , 2015, Molecules.
[22] James Z. Xing,et al. Excipient Interaction with Cetylpyridinium Chloride Activity in Tablet Based Lozenges , 2004, Pharmaceutical Research.
[23] Mitsuru Uchiyama. Regulatory Status of Excipients in Japan , 1999 .
[24] B B Wray,et al. Metabisulfite sensitivity: case report and literature review. , 1985, Annals of allergy.
[25] Bruno C. Hancock,et al. Differential scanning calorimetry: applications in drug development. , 1999, Pharmaceutical science & technology today.
[26] G. L. Pramod,et al. Global regulatory perspective of bulk pharmaceutical excipients , 2010 .
[27] R. Johnson,et al. Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine. , 1998, Journal of pharmaceutical sciences.
[28] A. Bernkop‐Schnürch,et al. Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[29] Roger A. Rajewski,et al. Cyclodextrins: Their Future in Drug Formulation and Delivery , 1997, Pharmaceutical Research.
[30] István Antal,et al. Comparative evaluation of the effect of cyclodextrins and pH on aqueous solubility of apigenin. , 2016, Journal of pharmaceutical and biomedical analysis.
[31] Robert Gurny,et al. Bioadhesion: Possibilities and Future Trends , 1990 .
[32] S. Chaudhari,et al. Pharmaceutical Excipients: A review , 2012 .
[33] M. Turner,et al. Why are Excipients Important to Neonates? , 2015, Current pharmaceutical design.
[34] S. Byrn,et al. Chemical reactivity in solid-state pharmaceuticals: formulation implications. , 2001, Advanced drug delivery reviews.
[35] Anna Tsantili-Kakoulidou,et al. The potential of immobilized artificial membrane chromatography to predict human oral absorption. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[36] T. Mamatha,et al. Drug-excipient interaction and its importance in dosage form development , 2011 .
[37] Loyd V. Allen,et al. Ansel'S Pharmaceutical Dosage Forms And Drug Delivery Systems , 2007 .
[38] E Napke,et al. Excipients and additives: hidden hazards in drug products and in product substitution. , 1984, Canadian Medical Association journal.
[39] Jatinder Singh. International conference on harmonization of technical requirements for registration of pharmaceuticals for human use , 2015, Journal of pharmacology & pharmacotherapeutics.
[40] Flavia Laffleur,et al. In vitro characterization of insulin containing thiomeric microparticles as nasal drug delivery system. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[41] Susan Thaul,et al. How FDA Approves Drugs and Regulates Their Safety and Effectiveness [May 18, 2012] , 2012 .
[42] K. Hartauer,et al. Influence of Peroxide Impurities in Povidone and Crospovidone on the Stability of Raloxifene Hydrochloride in Tablets: Identification and Control of an Oxidative Degradation Product , 2000, Pharmaceutical development and technology.
[43] Elias Mossialos,et al. Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality , 2004 .
[44] Sarfaraz Niazi,et al. Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products , 2016, Handbook of Pharmaceutical Manufacturing Formulations, Second Edition.
[45] Rick Ng. Drugs: From Discovery to Approval , 2004 .
[46] Hans P Merkle,et al. Drug delivery's quest for polymers: Where are the frontiers? , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[47] Lu Xu,et al. Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro. , 2016, Materials science & engineering. C, Materials for biological applications.
[48] Danièle Giron,et al. Contribution of thermal methods and related techniques to the rational development of pharmaceuticals—Part 2 , 1998 .
[49] P Mura,et al. Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy. , 1998, Journal of pharmaceutical and biomedical analysis.
[50] A. Yehia,et al. Chemometrics resolution and quantification power evaluation: Application on pharmaceutical quaternary mixture of Paracetamol, Guaifenesin, Phenylephrine and p-aminophenol. , 2016, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[51] Rolando Perdomo-Morales,et al. Soluble β-(1,3)-glucans enhance LPS-induced response in the monocyte activation test, but inhibit LPS-mediated febrile response in rabbits: Implications for pyrogenicity tests. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[52] L. Benet,et al. Effect of inert tablet ingredients on drug absorption. I. Effect of polyethylene glycol 4000 on the intestinal absorption of four barbiturates. , 1966, Journal of pharmaceutical sciences.
[53] Philippe Maincent,et al. Bioavailability study of tolbutamide β-cyclodextrin inclusion compounds, solid dispersions and bulk powder , 1993 .
[54] J. Sousa,et al. Compatibility Studies Between Ibuprofen or Ketoprofen with Cellulose Ether Polymer Mixtures Using Thermal Analysis , 2005, Drug development and industrial pharmacy.
[55] G Pifferi,et al. Drug impurities: problems and regulations. , 1999, Bollettino chimico farmaceutico.
[56] J. C. Callahan,et al. Equilibrium Moisture Content of Pharmaceutical Excipients , 1982 .
[57] Sarfaraz Niazi. Oral Solutions and Suspensions , 2016 .
[58] Véronique Nardello-Rataj,et al. Pickering emulsions based on cyclodextrins: A smart solution for antifungal azole derivatives topical delivery. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[59] R. Torres-Palma,et al. Comparative study of the effect of pharmaceutical additives on the elimination of antibiotic activity during the treatment of oxacillin in water by the photo-Fenton, TiO2-photocatalysis and electrochemical processes. , 2016, The Science of the total environment.
[60] Javier Ellena,et al. Mechanochemistry applied to reformulation and scale-up production of Ethionamide: Salt selection and solubility enhancement. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[61] Myra L. Weiner,et al. Excipient Toxicity and Safety , 1999 .
[62] Sudha Srivastava,et al. Conformation and macromolecular interaction of ACE inhibitors enalapril and lisinopril by NMR , 1994 .
[63] D H Gieringer,et al. The safety and efficacy of new drug approval. , 1985, The Cato journal.
[64] C. Goodman. United States Pharmacopeial Convention , 1988 .
[65] J L Lach,et al. Dissolution-dialysis method of assessing in vitro drug availability of prednisolone tablets. , 1973, American journal of hospital pharmacy.
[66] A Hertrampf,et al. Advanced qualification of pharmaceutical excipient suppliers by multiple analytics and multivariate analysis combined. , 2015, International journal of pharmaceutics.
[67] Arvind K. Bansal,et al. Coprocessed excipients for solid dosage forms , 2004 .
[68] D. B. Mitchell,et al. A new approach to the safety assessment of pharmaceutical excipients. The Safety Committee of the International Pharmaceutical Excipients Council. , 1996, Regulatory toxicology and pharmacology : RTP.
[69] W. Evering,et al. An assessment of the ocular safety of inactive excipients following sub-tenon injection in rabbits. , 2008, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[70] Maria Angela Vandelli,et al. The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica , 1988 .
[71] A. Weingart,et al. Oxidativer Abbau von Linolsäuremethylester in Suspension anorganischer Hilfsstoffe. I: Autoxidation in Gegenwart von Kieselsäureprodukten und Aluminiumoxid , 1987 .
[72] Pant,et al. Drug-excipient interactions and their affect on absorption. , 2000, Pharmaceutical science & technology today.
[73] A. Healy,et al. Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[74] Stephen Edge,et al. Adsorption of an Amine Drug onto Microcrystalline Cellulose and Silicified Microcrystalline Cellulose Samples , 2003, Drug development and industrial pharmacy.
[75] Donald C. Monkhouse,et al. Whither Compatibility Testing , 1989 .
[76] Qibin Zhang,et al. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. , 2009, Journal of proteome research.
[77] C. L. Winek. HISTORY OF EXCIPIENT SAFETY AND TOXICITY , 2000 .
[78] Sarfaraz Niazi,et al. Impurities in New Drug Products , 2016, Handbook of Pharmaceutical Manufacturing Formulations.
[79] Sanjay Garg,et al. Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations. , 2004, Journal of pharmaceutical and biomedical analysis.
[80] M. Son,et al. Enteric-coated tablet of risedronate sodium in combination with phytic acid, a natural chelating agent, for improved oral bioavailability. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[81] K. Ikeda,et al. Photo-enhanced modification of human skin elastin in actinic elastosis by N(epsilon)-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction. , 1997, The Journal of investigative dermatology.